Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$154.26 - $198.1 $4.29 Million - $5.51 Million
27,790 New
27,790 $4.68 Million
Q1 2021

Apr 30, 2021

SELL
$180.37 - $226.26 $7.14 Million - $8.96 Million
-39,598 Closed
0 $0
Q4 2020

Jan 29, 2021

SELL
$148.08 - $206.57 $2.98 Million - $4.15 Million
-20,095 Reduced 33.66%
39,598 $7.59 Million
Q3 2020

Oct 30, 2020

SELL
$122.51 - $158.27 $86,982 - $112,371
-710 Reduced 1.18%
59,693 $8.81 Million
Q2 2020

Aug 03, 2020

SELL
$94.33 - $140.48 $1.96 Million - $2.92 Million
-20,802 Reduced 25.62%
60,403 $7.47 Million
Q1 2020

Apr 30, 2020

SELL
$84.96 - $109.14 $3.52 Million - $4.52 Million
-41,455 Reduced 33.8%
81,205 $7.84 Million
Q4 2019

Jan 31, 2020

SELL
$73.84 - $93.08 $628,747 - $792,576
-8,515 Reduced 6.49%
122,660 $11.3 Million
Q3 2019

Nov 04, 2019

SELL
$76.65 - $95.51 $2.45 Million - $3.06 Million
-32,000 Reduced 19.61%
131,175 $10.1 Million
Q2 2019

Jul 31, 2019

SELL
$54.2 - $85.95 $60,704 - $96,264
-1,120 Reduced 0.68%
163,175 $14 Million
Q1 2019

May 01, 2019

SELL
$49.45 - $62.8 $1.46 Million - $1.86 Million
-29,575 Reduced 15.26%
164,295 $9.71 Million
Q4 2018

Jan 31, 2019

SELL
$48.26 - $68.88 $1.89 Million - $2.7 Million
-39,250 Reduced 16.84%
193,870 $10.2 Million
Q3 2018

Nov 13, 2018

SELL
$46.8 - $58.97 $1.1 Million - $1.39 Million
-23,490 Reduced 9.15%
233,120 $12.9 Million
Q2 2018

Aug 02, 2018

SELL
$35.26 - $47.04 $236,242 - $315,168
-6,700 Reduced 2.54%
256,610 $12.1 Million
Q1 2018

Apr 30, 2018

BUY
$30.92 - $37.27 $506,005 - $609,923
16,365 Added 6.63%
263,310 $9.53 Million
Q4 2017

Jan 31, 2018

BUY
$32.53 - $38.92 $2.57 Million - $3.07 Million
79,005 Added 47.04%
246,945 $8.96 Million
Q3 2017

Oct 31, 2017

BUY
$36.98 - $46.06 $6.21 Million - $7.74 Million
167,940
167,940 $6.44 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Kornitzer Capital Management Inc Portfolio

Follow Kornitzer Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.